High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort studyKnud Schewe, Christoph D. Spinner, Hans Jäger et al.|Infection|2020Cited by 17
Cost of Human Immunodeficiency Virus (HIV) and Determinants of Healthcare Costs in HIV-Infected Treatment-Naive Patients Initiated on Antiretroviral Therapy in Germany: Experiences of the PROPHET StudyFrederik Valbert, Anja Neumann, Eva Wolf et al.|Value in Health|2020Cited by 11
Socio-demographic and psycho-social determinants of HIV late presentation in Germany – results from the FindHIV studyPaul Lauscher, Eva Wolf, Nikola Hanhoff et al.|AIDS Care|2023Cited by 4